Harrow Health, Inc. (HROW) vs Replimune Group, Inc. (REPL)
A side-by-side comparison of Harrow Health, Inc. and Replimune Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HROW
Harrow Health, Inc.
$30.21HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
REPL
Replimune Group, Inc.
$13.01HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
Total return — HROW vs REPL
growth of $100 · dividends reinvested · last 8yHROW +1195.8% (+37.7%/yr)REPL -13.3% (-1.8%/yr)HROW compounded faster over this window
Log scale — wide-divergence pair
HROW REPL
HROW vs REPL: by the numbers
- •HROW is the larger company ($1.13B vs $1.09B market cap).
- •Both run net losses; REPL's is the smaller (0.00% vs -13.51% net margin).
Metrics side by side
Valuation
| Metric | HROW | REPL |
|---|---|---|
| P/S ratio | 4.09 | N/A |
| P/B ratio | 74.08 | 10.35 |
| FCF yield | 0.47% | N/A |
Profitability
| Metric | HROW | REPL |
|---|---|---|
| Gross margin | 73.28% | 0.00% |
| Operating margin | 14.18% | 0.00% |
| Net margin | -13.51% | 0.00% |
| ROE | -244.91% | -281.14% |
| ROIC | 1.81% | -139.11% |
Growth (annualized)
| Metric | HROW | REPL |
|---|---|---|
| Revenue CAGR (5Y) | 34.52% | N/A |
| Total return CAGR (5Y) | 27.66% | -15.17% |
Frequently asked
- How have HROW and REPL total returns compared?
- Over the past 5 years, HROW delivered 27.66% and REPL delivered -15.17% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Harrow Health ROEReplimune ROEHarrow Health operating marginReplimune operating marginHarrow Health revenue growthReplimune revenue growthHarrow Health free cash flowReplimune free cash flow
Harrow Health & Replimune appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.